A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00250367
Recruitment Status : Completed
First Posted : November 8, 2005
Last Update Posted : November 25, 2010
Information provided by:
Janssen Pharmaceutica N.V., Belgium